National Cancer Institute - Alliance for Nanotechnology in Cancer
U.S. National Institutes of Health | nano.cancer.gov
 
 
National Cancer Institute NCI Alliance for Nanotechnology in Cancer
Nanotechnology:
Critical Endeavor
in Cancer

>  Why Nanotechnology?
>  Nanowires
>  Cantilevers
>  Nanoshells
>  Nanoparticles

Nanotechnology
Centers of Excellence
>  Mission
Multidisciplinary
Research Teams
>  Mission
Nanotechnology
Platforms for Cancer
Research
>  Mission
Nanotechnology
Characterization
Lab (NCL)
>  Mission

Nanotech Highlights

Career Opportunity
Cancer Nanotechnology Program Manager
Closing Date: October 29, 2004
[Full Job Description]

NCAB Meeting
Tuesday, September 14, 2004
Mini-Symposium:
The Science of Nanotechnology
10:45am - 12:30pm
[Program Agenda]
[Speaker Bios]

Alliance Launch Day
Monday, September 13, 2004
Natcher Conference Center
NIH Bethesda, Maryland


Going Small For
Big Advances

Cancer Nanotechnology Brochure


Download This Brochure To
Learn More


Director's Statement

Message From The Director

Nanotechnology: Critical Endeavor in Cancer
Why Nanotechnology in Cancer - Nanowires - Cantilevers - Nanoshells - Nanoparticles

Nanotechnology: Critical Endeavor in Cancer


Reference: Arun Majumdar, University of California at Berkeley


Replay Animation


Previous Animation | Next Animation

Cantilevers

Nanoscale cantilevers – microscopic, flexible beams resembling a row of diving boards – are built using semiconductor lithographic techniques. These can be coated with molecules capable of binding specific substrates—DNA complementary to a specific gene sequence, for example. Such micron-sized devices, comprising many nanometer-sized cantilevers, can detect single molecules of DNA or protein.

As a cancer cell secretes its molecular products, the antibodies coated on the cantilever fingers selectively bind to these secreted proteins. These antibodies have been designed to pick up one or more different, specific molecular expressions from a cancer cell. The physical properties of the cantilevers change as a result of the binding event. Researchers can read this change in real time and provide not only information about the presence and the absence but also the concentration of different molecular expressions.

Nanoscale cantilevers, constructed as part of a larger diagnostic device, can provide rapid and sensitive detection of cancer-related molecules.

Reference Scientific Bibliography:
   Cancer Detection/Diagnosis via Nanotechnologies and Nanosensors

 

   



A Service of the National Cancer Institute
Department of Health and Human ServicesNational Institutes of HealthFirstGov.gov